Hong Kong Sanatorium & Hospital
Hong Kong
NCT Number: NCT05373459
A new wave of COVID-19 infections, mainly caused by the Omicron/ Delta variant, has been sweeping the globe since the start of 2022. In response, the administration of a third dose of COVID-19 vaccine was considered to address potential waning immunity over time and reduced effectiveness against the Omicron/ Delta variant. The pandemic also resulted in many infections among health care workers (HCWs) and their households. In this study, a retrospective analysis would perform on risk of COVID-19 infection and their outcome in relation to their COVID-19 vaccination history by using the data repository from one of the Hong Kong private hospitals.
HCWs were required to submit a standardized online self-declaration form for report of 1) demographic of the HCWs, 2) symptoms related history and 3) COVID-19 exposure history once they were COVID-19 confirmed by rapid antigen test against COVID-19 and/or polymerase chain reaction (PCR) test for COVID-19. Subsequent follow up such as contact tracing, COVID-19 PCR testing results of these HCWs and status of return to work were captured by the infection control team in a systematic manner.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Hong Kong
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Third COVID-19 booster
Time frame: During 1 February - 31 March 2022
Number of participants with COVID-19 infected
Time frame: During 1 February - 31 March 2022
Number of days return to work after COVID-19 infection
Hong Kong Sanatorium & Hospital
Industry
Effect of a Third COVID-19 Booster on COVID-19 Infection Rate and Return to Works During Fifth Wave COVID-19 Among Health Care Workers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05096260
COVID-19, COVID-19 Pandemic
Ann Arbor, Michigan, United States
View Trial DetailsNCT05012943
COVID-19, COVID-19 Vaccines
Hanoi, Vietnam
View Trial DetailsNCT06199934
COVID-19, COVID-19 Vaccines
New York, United States
View Trial DetailsNCT06989307
Antibodies, Viral, COVID-19
Saint-Denis, France
View Trial Details